“Existing technologies will not deliver the breakthrough performance required to realize the full potential of the DNA economy … something different, and truly innovative is required.”

— Paul Mola, CEO and Founder

Our Goal: Precision Medicine

Current prevention and treatment of disease is not precisely tailored to each individual's unique variability in genes, environment and lifestyle. Precision medicine should begin with complete knowledge of the individual's genome, however, current whole-genome DNA sequencing technology is still too costly, too complex and low accuracy to use in precision medicine at the population scale. Roswell's sequencing technology was specifically designed to disrupt the current technologies and deliver an "endgame" sequencing platform, ideal for the future of global precision medicine.

Our Team

The Roswell founders and leadership team have uniquely broad and deep experience in genomics, from fundamental technology development, to global commercialization, to population-scale applications. We are comprised of seasoned business leaders and experienced scientists, engineers and technologists, on a mission to revolutionize precision medicine.
Learn More

Leadership Team

Paul Mola

President, CEO & Founder, Director

Paul Mola is the Chief Executive Officer and President of Roswell Biotechnologies, Inc., and a member of the company's board of directors. He founded Roswell in 2014, bringing more than 20 years of Life Science industry leadership and executive experience to the company. Paul manages corporate direction and strategy combining science and business knowledge to build highly talented and effective teams across corporate, business and technical functions. Previously, Paul was Head of Global Solutions at Human Longevity, Inc., working with genome sequencing pioneer Craig Venter to establish international precision medicine partnerships.
Barry M

Barry Merriman, Ph.D.

CSO & Co-Founder, Director

Dr. Merriman is the co-Founder and Chief Science Officer of Roswell Biotechnologies, and a member of the company's board of directors. Dr. Merriman brings to the company over 30 years of broad experience in scientific research and technology development, with deep expertise in DNA sequencing technology and associated applications. Dr. Merriman is the architect of the Roswell technology roadmap, oversees the company's research and development, leads the creation of its intellectual property, and builds strategic relationships with science and technology partners. Dr. Merriman has published extensively in the scientific literature and is a highly regarded international lecturer in these fields.

Tim Geiser, Ph.D.

Head of Intellectual Property and Licensing

Dr. Geiser is the Vice President of Intellectual Property and Licensing at Roswell Biotechnologies. Dr. Geiser has over 40 years of experience in life sciences technology and business development. His achievements include pioneering the development of the first instruments for DNA synthesis and peptide synthesis, two cornerstones of modern biotechnology. Dr. Geiser manages Roswell's IP portfolio, leads licensing efforts, and plays a key role in developing the company's IP strategy and strategic partnerships.

Sungho Jin, Ph.D.

Head of Nanofabrication

Dr. Jin is the Chief Architect for Nanofabrication at Roswell. He brings to the company over 40 years of experience as a leading authority in materials science and nanofabrication. Dr. Jin is a Professor Emeritus at the University of California, San Diego, where he was a Distinguished Professor of Materials Science and held the Sony Endowed Chair in Engineering. Prior to that, Dr. Jin was one of the elite group of Technical Directors at Bell Labs, overseeing the area of Applied Materials. Dr. Jin is internationally recognized as one of the leading experts in nanotechnology and has won numerous national honors.

Drew Hall, Ph.D.

Head of Chip Design

Dr. Hall is the Chief Architect for Chip Design at Roswell Biotechnologies. He brings to the company cutting-edge industry experience in designing CMOS chips for high-performance biosensors. Dr. Hall is the architect of the Roswell chip technology roadmap, leads the company's chip design program, and manages the chip design and electrical engineering teams. In addition to his work at Roswell, Dr. Hall holds a position as Assistant Professor in Electrical Engineering at University of California, San Diego, where he leads the Biosensor Research Program. Dr. Hall has an extensive background in designing CMOS integrated circuits for bioelectronics, biosensors, lab-on-chip devices, and other biomedical devices and systems.

Eskild Hansen

Chief Design Officer

Eskild Hansen is the founder of Eskild Hansen Design Studios and Chief Design Officer of international companies that have focus on taking design to the next level Before this he was the Global Director of Design at Coloplast, responsible for the global design strategy, the multi-disciplinary design team, projects and for external partners. The vision was to use design to create the most innovative medical device company in the world Before this, Eskild was the Head of the Cisco European Design Center. Over the six years in this leadership role, he managed the multi-disciplinary European design team and formulated the vision and strategies for the implementation and execution of large global Cisco Consumer projects.
Michael Geremia

Michael Geremia

Head of Finance

Michael Geremia is Roswell’s VP of Finance. He brings to the company over 13 years of experience in senior finance and executive leadership roles in biotech startups and growth enterprises. Michael manages financial activity and is a member of the executive team leading Roswell to bring its proprietary molecular electronics END-Seq sequencing technology to market. Previously, Michael was CFO at Vala Sciences, where he was responsible for finance and strategy, and helped lead commercialization of its first-in-class cellular analysis tools for drug discovery.

Scientific Advisory Board

Professor James Tour

Rice University Departments of Chemistry, Computer Science, Materials Science, and NanoEngineering, member of AAAS and NAI.
Professor Tour is regarded as one of the fathers of Molecular Electronics having lead the effort to make the first molecular circuit, which was heralded by the Journal Science as a Breakthrough of the Year in 2000. Professor Tour advises Roswell on all areas regarding Molecular Electronics including molecular conductors, molecular circuits, and synthetic chemistry for nanotechnology. Professor Tour is an expert in synthetic organic chemistry for diverse applications in nanotechnology and nanoelectronics, and is Director of the Center for Carbon Nanotechnology at Rice University. He has received numerous honors for his pioneering work in molecular electronics and nanotechnology.

Professor Eli Yablonovitch

UC Berkeley Department of Electrical Engineering and Computer Science
Professor Yablonovitch is a world leading expert in quantum electronics, quantum photonics, and nano-scale engineering. Professor Yablonovitch advices Roswell in the fiels of nanotechnology including nano-Electronics, nano-Fabrication, and semiconductors. He has received numerous awards for his fundamental contributions in physics and engineering, including the Isaac Newton Medal and the Edison Medal, two of the highest honors in these fields. He is recognized as one of the fathers of modern photonics and the Inventor of the Photonics Crystal, a foundational technology for semiconductors in communication.

Professor Stanley Osher

UCLA Departments of Mathematics and Computer Science
Professor Osher is a world-leading expert in Data Sciences and the development of algorithms for computer simulation and data analysis. He advises Roswell in the area of Informatics, including signal processing, data analysis, algorithms, and data science. He has received many awards for his fundamental contributions to the fields of applied math, computational math, and computer science. Professor Osher is the Director of Special Projects at IPAM, a US National Research Center for Pure and Applied Mathematics. Professor Osher is one of the most widely cited computer scientists in history and is widely recognized as the father of modern signal processing methods.

Professor George Church

Harvard University Department of Genetics
Professor Church is a world leading expert in the technologies used to study and manipulate the genome, and a pioneer in DNA sequencing technology, genome editing technology, and synthetic biology. He advises Roswell in the area of Genomics, including protein engineering, synthetic biology and genomic technology. He has won numerous awards for his fundamental contributions to genomics, including the Bower Award for Achievement in Science, and the American Society for Microbiology Biotechnology Research Award. Professor Church introduced many of the techniques fundamental to current genome sequencing technology, has cofounded numerous companies in the areas of genomics and genetics, and was one of the originators of the Human Genome Project.

Professor Sandy Schmid

UT Southwestern Department of Cellular and Molecular Biology
Professor Schmid is an expert in fundamental processes of cellular biology. She advises Roswell in the area of Molecular Biology, including protein engineering, biochemistry, and molecular conjugation. She is a Distinguished Chair in Cellular and Molecular Biology and Chairman of the Department of Cell Biology at UT Southwestern Medical Center. She was previously Chairman of the Department of Cellular and Molecular Biology at Scripps Research Institute in San Diego. She is a member of the American Academy of Arts and Sciences and President of the American Society for Cell Biology.

Professor Stanley F. Nelson, MD

UCLA Departments of Human Genetics, Pediatrics, and Psychiatry
Professor Nelson is a leading expert in the development and application of genomic technologies for use in medicine and medical research. He advises Roswell in the area of Medical Applications of Genomics, including genetic disease, clinical sequencing, biomarkers, and drug discovery. Dr. Nelson is credited with inventing the original DNA microarray technology and its applications to genomics at the Brown Lab in Stanford in 1990. This technology provided the foundation for much of modern genomics research, as well as the later development of Next Generation Sequencing technology. Dr. Nelson has done extensive work finding the genes responsible for human inherited disease and cancer, as well as developing genomics-based therapies for genetic disease.